Six months vitamin K treatment does not affect systemic arterial calcification or bone mineral density in diabetes mellitus 2

Abstract

Purpose Vitamin K-dependent proteins are involved in (patho)physiological calcification of the vasculature and the bones. Type 2 diabetes mellitus (DM2) is associated with increased arterial calcification and increased fractures. This study investigates the effect of 6 months vitamin K2 supplementation on systemic arterial calcification and bone mineral density (BMD) in DM2 patients with a history of cardiovascular disease (CVD). Methods In this pre-specified, post hoc analysis of a double-blind, randomized, controlled clinical trial, patients with DM2 and CVD were randomized to a daily, oral dose of 360 µg vitamin K2 or placebo for 6 months. CT scans were made at baseline and follow-up. Arterial calcification mass was quantified in several large arterial beds and a total arterial calcification mass score was calculated. BMD was assessed in all non-fractured thoracic and lumbar vertebrae. Results 68 participants were randomized, 35 to vitamin K2 (33 completed follow-up) and 33 to placebo (27 completed follow-up). The vitamin K group had higher arterial calcification mass at baseline [median (IQR): 1694 (812–3584) vs 1182 (235–2445)] for the total arterial calcification mass). Six months vitamin K supplementation did not reduce arterial calcification progression (β [95% CI]: − 0.02 [− 0.10; 0.06] for the total arterial calcification mass) or slow BMD decline (β [95% CI]: − 2.06 [− 11.26; 7.30] Hounsfield units for all vertebrae) when compared to placebo. Conclusion Six months vitamin K supplementation did not halt progression of arterial calcification or decline of BMD in patients with DM2 and CVD. Future clinical trials may want to pre-select patients with very low vitamin K status and longer follow-up time might be warranted. This trial was registered at clinicaltrials.gov as NCT02839044

The Dual Role of Vitamin K2 in “Bone-Vascular Crosstalk”: Opposite Effects on Bone Loss and Vascular Calcification

“…However, despite the encouraging results mentioned above, no association has been found between VitK2 intake, reduced stroke risk [ 122 ], CVD mortality [ 127 ] and arterial calcification in Type 2 diabetes and CVD patients [ 128 , 129 ].…”

Vitamin K2—a neglected player in cardiovascular health: a narrative review

“…A post-hoc analysis of this trial was recently published to investigate the effect of vitamin K 2 on CT-based arterial calcification mass, quantified in several large arterial beds, and there was no significant difference between placebo and supplemented groups. 111 Both studies were limited by the short duration of follow-up, small sample size, low percentage of severe vitamin K deficiency and high dropout rates. Despite the evident potential of vitamin K 2 in modulating vascular and valvular calcification, its definitive role is yet to be fully established.…”

Matrix-GLA-Protein and Vascular Calcification: Can Diet Influence the Consequences of Matrix GLA Protein Inactivation? A Review

“…While some studies, especially in female postmenopausal patients after vitamin K1 supplementation showed an unchanged atherosclerotic index in the carotid comm. artery, in some studies these were even decreased [112,113] .…”